Patient advocate startup Solace is set to be valued at over $300 million in new funding round from Menlo Ventures
2 Articles
2 Articles


Patient advocate startup Solace is set to be valued at over $300 million in new funding round from Menlo Ventures
Juan Moyano/Getty ImagesSolace is raising a Series B funding round led by Menlo Ventures, Business Insider has learned.Solace connects patients with healthcare advocates to simplify tasks like scheduling and payments.Sources with knowledge of the deal said the new round values Solace at more than $300 million.Buzzy healthcare startup Solace just raised a fresh round of funding led by VC firm Menlo Ventures, Business Insider has learned.Solace, w…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage